Swelling Linked to Experimental Drug
 

BACK

(Bloomberg News) - The Elan Corporation's experimental treatment for Alzheimer's disease has been linked to more cases of inflammation of the central nervous system, a side effect that caused the company to suspend a study last month.

Last month, Elan, Ireland's biggest drug maker, and its partner, the American Home Products Corporation (news/quote), said they had halted the test after four patients developed the inflammation, which resembles encephalitis.

The Washington Post (news/quote) reported on Thursday that the condition might have afflicted a total of 12 volunteers out of about 360 in the research.

"The only thing I can say is that there are some additional cases," said Jonathan Birt, a spokesman for Elan. He declined to give further numbers or to predict the future of the new drug.

All the findings will be reviewed by the study's independent monitoring board and sent to regulators, he said.

Investors had considered the medicine, known as AN-1792, one of the most promising in development at Elan.

 


Home | Our Center | Dr. Braciszewski | F.A.Q. | Discussions | News | Links | Email Us

Web Site Design and Maintained by: Web Weavers, Inc.
All Rights Reserved

Web Site Links Disclaimer: At certain places in this site, links to other web sites can be accessed. Links to other Internet sites are provided as a convenience only. These sites contain information created, published, and maintained by organizations independent of AARC,Inc..
We do not endorse, approve, certify or control these web sites or the opinions, information, products or services contained therein, and do not guarantee the accuracy, completeness, efficacy or timeliness of information located therein, or at any link contained in a linked site. Internet locations change frequently, so many of the links provided on this web site may no longer access the external web sites listed herein.
No Medical Advice: The information posted here is not intended to be and should not be considered medical advice, as it is designed to support, not replace, the relationship that exists between a patient and his or her existing healthcare provider. It is not a substitute for the professional medical advice, diagnosis or treatment provided by your physician, other qualified health provider or any information included by the manufacturer with or on any product. Never disregard professional medical advice or delay in seeking it because of something you have read on or through the AARC web site. If you think you may have a medical emergency, call your doctor or 911 immediately.
YOU SHOULD ALWAYS CONSULT A PHYSICIAN OR OTHER HEALTHCARE PROVIDER OF YOUR OWN CHOICE AND CAREFULLY READ ALL PACKAGING AND OTHER INFORMATION PROVIDED BY THE MANUFACTURER OF ANY MEDICAL PRODUCTS OR DEVICES BEFORE USING THEM.